title: Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.
authors.forename: Ian C
authors.initials: IC
authors.lastname: Gilchrist
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods / Q000401:mortality; D001803:Blood Transfusion; D004638:Emergency Treatment; D005263:Femoral Artery; D006470:Hemorrhage / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D017410:Practice Guidelines as Topic; D011677:Punctures; D017534:Radial Artery; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D014481:United States
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex